Orally Administrable H2 S-Scavenging Metal-Organic Framework Prepared by Co-Flow Microfluidics for Comprehensive Restoration of Intestinal Milieu
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
82273873
National Natural Science of China
21JCYBJC00660
Tianjin Natural Science Foundation
0701320001
Young Elite Scientists Sponsorship Program by Tianjin
0402080005
Major Special Projects
PubMed
36637449
DOI
10.1002/adma.202210047
Knihovny.cz E-zdroje
- Klíčová slova
- Zr metal-organic frameworks, hydrogen sulfide scavenging, inflammatory bowel disease, intestinal milieu restoration, microfluidic technology,
- MeSH
- mikrofluidika MeSH
- porézní koordinační polymery * metabolismus MeSH
- střeva MeSH
- střevní sliznice metabolismus MeSH
- sulfan chemie MeSH
- těsný spoj MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- porézní koordinační polymery * MeSH
- sulfan MeSH
- UiO-66 MeSH Prohlížeč
Intestinal milieu disorders are strongly related to the occurrence of inflammatory bowel diseases (IBDs), which results from mucosa destruction, epithelium disruption, and tight junction (TJ) proteins loss. Excess of H2 S in the intestinal milieu produced by the sulfate-reducing bacteria metabolism contributes to development of IBDs via epithelial barrier breakdown. Conventional interventions, such as surgery and anti-inflammatory medications, are considered not completely effective because of frequent recurrence and other complications. Herein, a novel oral delivery system, a hydroxypropyl methylcellulose acetate succinate (HPMCAS)-based polymer-coated Zr-based metal-organic framework (UiO-66) with a Cux -rhodamine B (CR) probe (hereinafter referred to as HUR), is produced via a co-flow microfluidic approach with the ability to reduce H2 S levels, thus restoring the intestinal lumen milieu. HPMCAS serves as an enteric coating that exposes UiO-66@CR at the pH of the intestine but not the acidic pH of the stomach. The synthesized HUR exhibits notable therapeutic efficacy, including mucosa recovery, epithelium integrity restoration, and TJ proteins upregulation via H2 S scavenging to protect against intestinal barrier damage and microbiome dysbiosis. Thus, HUR is verified to be a promising theranostic platform able to decrease the H2 S content for intestinal milieu disorder treatment. The presented study therefore opens the door for further exploitation for IBDs therapy.
Zobrazit více v PubMed
G. G. Kaplan, S. C. Ng, Gastroenterology 2017, 152, 313.
a) J. T. Chang, N. Engl. J. Med. 2020, 383, 2652;
b) Y. Lee, K. Sugihara, M. G. Gillilland, 3rd, S. Jon, N. Kamada, J. J. Moon, Nat. Mater. 2020, 19, 118.
a) K. Parikh, A. Antanaviciute, D. Fawkner-Corbett, M. Jagielowicz, A. Aulicino, C. Lagerholm, S. Davis, J. Kinchen, H. H. Chen, N. K. Alham, N. Ashley, E. Johnson, P. Hublitz, L. Bao, J. Lukomska, R. S. Andev, E. Björklund, B. M. Kessler, R. Fischer, R. Goldin, H. Koohy, A. Simmons, Nature 2019, 567, 49;
b) B. A. A. Talebi, Front. Med. 2014, 1, 18.
a) J. D. Schulzke, S. Ploeger, M. Amasheh, A. Fromm, S. Zeissig, H. Troeger, J. Richter, C. Bojarski, M. Schumann, M. Fromm, Ann. N. Y. Acad. Sci. 2009, 1165, 294;
b) J. Landy, E. Ronde, N. English, S. K. Clark, A. L. Hart, S. C. Knight, P. J. Ciclitira, H. O. Al-Hassi, World J. Gastroenterol. 2016, 22, 3117.
B. Shen, Nat. Rev. Gastroenterol. Hepatol. 2017, 14, 693.
a) D. S. Wilson, G. Dalmasso, L. Wang, S. V. Sitaraman, D. Merlin, N. Murthy, Nat. Mater. 2010, 9, 923;
b) N. Sela-Passwell, R. Kikkeri, O. Dym, H. Rozenberg, R. Margalit, R. Arad-Yellin, M. Eisenstein, O. Brenner, T. Shoham, T. Danon, A. Shanzer, I. Sagi, Nat. Med. 2012, 18, 143;
c) A. Stallmach, S. Hagel, T. Bruns, Best Pract. Res., Clin. Gastroenterol. 2010, 24, 167.
D. Dordević, S. Jančíková, M. Vítězová, I. Kushkevych, J. Adv. Res. 2021, 27, 55.
a) N. Ijssennagger, C. Belzer, G. J. Hooiveld, J. Dekker, S. W. C. van Mil, M. Müller, M. Kleerebezem, R. van der Meer, Proc. Natl. Acad. Sci. U. S. A. 2015, 112, 10038;
b) N. Ijssennagger, R. van der Meer, S. W. C. van Mil, Trends Mol. Med. 2016, 22, 190.
a) M. W. Friederich, A. F. Elias, A. Kuster, L. Laugwitz, A. A. Larson, A. P. Landry, L. Ellwood-Digel, D. M. Mirsky, D. Dimmock, J. Haven, H. Jiang, K. N. MacLean, K. Styren, J. Schoof, L. Goujon, T. Lefrancois, M. Friederich, C. R. Coughlin 2nd, R. Banerjee, T. B. Haack, J. L. K. Van Hove, J. Inherited Metab. Dis. 2020, 43, 1024;
b) B. D. Paul, S. H. Snyder, K. Kashfi, Redox Biol. 2021, 38, 101772;
c) Z. Al Nabhani, S. Dulauroy, E. Lécuyer, B. Polomack, P. Campagne, M. Berard, G. Eberl, Nat. Metab. 2019, 1, 1101.
a) M. Ozekmekci, G. Salkic, M. F. Fellah, Fuel Process. Technol. 2015, 139, 49;
b) M. Daraee, R. Saeedirad, A. Rashidi, J. Solid State Chem. 2019, 278, 120866;
c) G. O. Yahaya, M. S. Qahtani, A. Y. Ammar, A. A. Bahamdan, A. W. Ameen, R. H. Alhajry, M. M. B. Sultan, F. Hamad, Chem. Eng. J. 2016, 304, 1020;
d) W. Heilman, V. Tammela, J. A. Meyer, V. Stannett, M. Szwarc, Ind. Eng. Chem. 1956, 48, 821.
Y. Zhou, Z. Chen, D. Zhao, D. Li, C. He, X. Chen, Adv. Mater. 2021, 33, 2102044.
W. Fan, Q. Wei, J. Xiang, Y. Tang, Q. Zhou, Y. Geng, Y. Liu, R. Sun, L. Xu, G. Wang, Y. Piao, S. Shao, Z. Zhou, J. Tang, T. Xie, Z. Li, Y. Shen, Adv. Mater. 2022, 34, 2109189.
a) P.-W. Ren, X.-J. Ju, R. Xie, L.-Y. Chu, J. Colloid Interface Sci. 2010, 343, 392;
b) H. Zhang, D. Liu, M. A. Shahbazi, E. Makila, B. Herranz-Blanco, J. Salonen, J. Hirvonen, H. A. Santos, Adv. Mater. 2014, 26, 4497;
c) S. A. Chew, V. A. Hinojosa, M. A. Arriaga, J. Biomed. Mater. Res., Part B 2018, 106, 2109.
J. Brady, T. Dürig, P. I. Lee, J. X. Li, in Developing Solid Oral Dosage Forms, 2nd ed., (Eds: Y. Qiu, Y. Chen, G. G. Z. Zhang, L. Yu, R. V. Mantri), Academic Press, Boston, MA, USA 2017, pp. 181-223.
a) S. Zhang, R. Langer, G. Traverso, Nano Today 2017, 16, 82;
b) B. Tirosh, N. Khatib, Y. Barenholz, A. Nissan, A. Rubinstein, Mol. Pharmaceutics 2009, 6, 1083.
I. A. Lazaro, S. Haddad, S. Sacca, C. Orellana-Tavra, D. Fairen-Jimenez, R. S. Forgan, Chem 2017, 2, 561.
S. Zhang, J. Ermann, M. D. Succi, A. Zhou, M. J. Hamilton, B. Cao, J. R. Korzenik, J. N. Glickman, P. K. Vemula, L. H. Glimcher, G. Traverso, R. Langer, J. M. Karp, Sci. Transl. Med. 2015, 7, 300ra128.
E. Rath, A. Moschetta, D. Haller, Nat. Rev. Gastroenterol. Hepatol. 2018, 15, 497.
J. Jiang, A. Chan, S. Ali, A. Saha, K. J. Haushalter, W.-L. M. Lam, M. Glasheen, J. Parker, M. Brenner, S. B. Mahon, H. H. Patel, R. Ambasudhan, S. A. Lipton, R. B. Pilz, G. R. Boss, Sci. Rep. 2016, 6, 20831.
V. Dhople, A. Krukemeyer, A. Ramamoorthy, Biochim. Biophys. Acta, Biomembr. 2006, 1758, 1499.
a) M. Schirmer, A. Garner, H. Vlamakis, R. J. Xavier, Nat Rev Microbiol. 2019, 17, 479;
b) R. B. Sartor, G. D. Wu, Gastroenterology 2017, 152, 327.
a) P. D. Cani, W. M. de Vos, Front. Microbiol. 2017, 8, 1765;
b) Z. Zhang, X. Wu, S. Cao, M. Cromie, Y. Shen, Y. Feng, H. Yang, L. Li, Front. Microbiol. 2017, 8, 1765.
M. A. R. Vinolo, H. G. Rodrigues, R. T. Nachbar, R. Curi, Nutrients 2011, 3, 858.
A. Yuan, C. Hao, X. Wu, M. Sun, A. Qu, L. Xu, H. Kuang, C. Xu, Adv. Mater. 2020, 32, 1906580.
W. Li, Y. Li, Z. Liu, N. Kerdsakundee, M. Zhang, F. Zhang, X. Liu, T. Bauleth-Ramos, W. Lian, E. Makila, M. Kemell, Y. Ding, B. Sarmento, R. Wiwattanapatapee, J. Salonen, H. Zhang, J. T. Hirvonen, D. Liu, X. Deng, H. A. Santos, Biomaterials 2018, 185, 322.
B. Chassaing, J. D. Aitken, M. Malleshappa, M. Vijay-Kumar, Curr. Protoc. Immunol. 2014, 104, 15.25.1.